HSD17B13-IN-4 (Compound 95) is an inhibitor of hydroxysteroid 17beta-dehydrogenase 13 (HSD17B13) with a Ki value of 50 nM for the estradiol substrate LCMS. HSD17B13-IN-4 can be used in the research of liver diseases, metabolic disorders, or cardiovascular diseases such as NAFLD or NASH, or drug-induced liver injury (DILI)[1].
Molekulargewicht:
591.39
Formel:
C26H15Cl2F3N4O3S
Target-Kategorie:
17beta-HSD
Anwendungsbeschreibung:
MCE Product type: Reference compound1
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
